HighTower Advisors
IBB icon

HighTower Advisors’s iShares Biotechnology ETF IBB Stock Holding History

HighTower Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed -$2K – 3375
2022
Q1 		$2K Buy
+3
New +$391 ﹤0.01% 3340
2017
Q1 		– Sell
-84,000
Closed -$2K – 2121
2016
Q4 		$2K Buy
+84,000
New +$7.65M ﹤0.01% 1909

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HighTower Advisors's IBB Position: Q1 2026 in Review

HighTower Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.55% in Q1 2026, buying an estimated $65.8K and bringing the position to 70,904 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #807.

HighTower Advisors first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q1 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • HighTower Advisors held 70,904 shares of iShares Biotechnology ETF worth $12M as of Q1 2026.
  • HighTower Advisors bought 385 iShares Biotechnology ETF shares in Q1 2026, an estimated $65.8K.
  • iShares Biotechnology ETF made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #807 holding.
  • HighTower Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's iShares Biotechnology ETF position peaked at $13M in Q1 2019.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.